95 related articles for article (PubMed ID: 16842233)
1. Syntheses, molecular targets and antitumor activities of novel triptycene bisquinones and 1,4-anthracenedione analogs.
Hua DH; Lou K; Battina SK; Zhao H; Perchellet EM; Wang Y; Perchellet JP
Anticancer Agents Med Chem; 2006 Jul; 6(4):303-18. PubMed ID: 16842233
[TBL] [Abstract][Full Text] [Related]
2. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling.
Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562
[TBL] [Abstract][Full Text] [Related]
3. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
4. Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities.
Wang B; Perchellet EM; Wang Y; Tamura M; Hua DH; Perchellet JP
Anticancer Drugs; 2003 Aug; 14(7):503-14. PubMed ID: 12960734
[TBL] [Abstract][Full Text] [Related]
5. Induction of poly(ADP-ribose) polymerase-1 cleavage by antitumor triptycene bisquinones in wild-type and daunorubicin-resistant HL-60 cell lines.
Wang Y; Perchellet EM; Tamura M; Hua DH; Perchellet JP
Cancer Lett; 2002 Dec; 188(1-2):73-83. PubMed ID: 12406551
[TBL] [Abstract][Full Text] [Related]
6. Novel substituted 1,4-anthracenediones with antitumor activity directly induce permeability transition in isolated mitochondria.
Perchellet EM; Wang Y; Lou K; Zhao H; Battina SK; Hua DH; Perchellet JP
Int J Oncol; 2007 Nov; 31(5):1231-41. PubMed ID: 17912452
[TBL] [Abstract][Full Text] [Related]
7. Antitumor triptycene analogs induce a rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria.
Wang Y; Perchellet EM; Ward MM; Lou K; Zhao H; Battina SK; Wiredu B; Hua DH; Perchellet JP
Int J Oncol; 2006 Jan; 28(1):161-72. PubMed ID: 16327993
[TBL] [Abstract][Full Text] [Related]
8. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
Perchellet EM; Magill MJ; Huang X; Brantis CE; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Sep; 10(8):749-66. PubMed ID: 10573208
[TBL] [Abstract][Full Text] [Related]
9. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro.
Perchellet EM; Sperfslage BJ; Wang Y; Huang X; Tamura M; Hua DH; Perchellet JP
Anticancer Drugs; 2002 Jul; 13(6):567-81. PubMed ID: 12172502
[TBL] [Abstract][Full Text] [Related]
10. Antitumor triptycene analogs directly interact with isolated mitochondria to rapidly trigger markers of permeability transition.
Perchellet EM; Wang Y; Lou K; Zhao H; Battina SK; Hua DH; Perchellet JP
Anticancer Res; 2007; 27(5A):3259-71. PubMed ID: 17970069
[TBL] [Abstract][Full Text] [Related]
11. Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones.
Wang Y; Perchellet EM; Ward MM; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2005 Oct; 16(9):953-67. PubMed ID: 16162972
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and proapoptotic activities of pyranoxanthenones, pyranothioxanthenones and their pyrazole-fused derivatives in HL-60 cells.
Perchellet EM; Ward MM; Skaltsounis AL; Kostakis IK; Pouli N; Marakos P; Perchellet JP
Anticancer Res; 2006; 26(4B):2791-804. PubMed ID: 16886598
[TBL] [Abstract][Full Text] [Related]
13. Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
Wu M; Wang B; Perchellet EM; Sperfslage BJ; Stephany HA; Hua DH; Perchellet JP
Anticancer Drugs; 2001 Nov; 12(10):807-19. PubMed ID: 11707648
[TBL] [Abstract][Full Text] [Related]
14. 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
Perchellet EM; Magill MJ; Huang X; Dalke DM; Hua DH; Perchellet JP
Anticancer Drugs; 2000 Jun; 11(5):339-52. PubMed ID: 10912950
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic response of HL-60 human leukemia cells to the antitumor drug NB-506, a glycosylated indolocarbazole inhibitor of topoisomerase 1.
Facompre M; Goossens JF; Bailly C
Biochem Pharmacol; 2001 Feb; 61(3):299-310. PubMed ID: 11172734
[TBL] [Abstract][Full Text] [Related]
16. New anthracenedione derivatives with improved biological activity by virtue of stable drug-DNA adduct formation.
Mansour OC; Evison BJ; Sleebs BE; Watson KG; Nudelman A; Rephaeli A; Buck DP; Collins JG; Bilardi RA; Phillips DR; Cutts SM
J Med Chem; 2010 Oct; 53(19):6851-66. PubMed ID: 20860366
[TBL] [Abstract][Full Text] [Related]
17. M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe.
Evison BJ; Pastuovic M; Bilardi RA; Forrest RA; Pumuye PP; Sleebs BE; Watson KG; Phillips DR; Cutts SM
Biochem Pharmacol; 2011 Dec; 82(11):1604-18. PubMed ID: 21889927
[TBL] [Abstract][Full Text] [Related]
18. Bioactivity and molecular targets of novel substituted quinolines in murine and human tumor cell lines in vitro.
Perchellet EM; Crow KR; Gakhar G; Nguyen TA; Shi A; Hua DH; Perchellet JP
Int J Oncol; 2010 Mar; 36(3):673-88. PubMed ID: 20126988
[TBL] [Abstract][Full Text] [Related]
19. Comparison of aza-anthracenedione-induced DNA damage and cytotoxicity in experimental tumor cells.
Hazlehurst LA; Krapcho AP; Hacker MP
Biochem Pharmacol; 1995 Sep; 50(7):1087-94. PubMed ID: 7575665
[TBL] [Abstract][Full Text] [Related]
20. Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways.
Chiang JH; Yang JS; Ma CY; Yang MD; Huang HY; Hsia TC; Kuo HM; Wu PP; Lee TH; Chung JG
Chem Res Toxicol; 2011 Jan; 24(1):20-9. PubMed ID: 21126053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
